Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR (NASDAQ:EVO) in a deal valued at approximately 2 billion euros ($2.10 billion), to ...
MarketWatch6h
Evotec Shares Surge on $2.11 Billion Buyout Offer
The German drug developer confirmed media reports that Halozyme Therapeutics submitted an all-cash bid of 11 euros a share, which represents a 27% premium to Evotec's last closing share price. "The ...
TT Electronics Shares Soar After Rejecting $315 Mln Volex Takeover Approach
Power and data-cabling company Volex said it submitted two proposals to the board of TT Electronics for a possible cash and shares offer. One proposal implied a price of 129.0 pence per TT Electronics ...